# FDA Inspection 1014326 - Grifols Biomat - May 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/grifols-biomat/83969a48-f681-441b-a04d-04b3003a2a2f
Source feed: FDA_Inspections

> FDA Inspection 1014326 for Grifols Biomat on May 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014326
- Company Name: Grifols Biomat
- Inspection Date: 2017-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1106731 - 2019-09-19](https://www.keypedia.com/records/fda_inspections/grifols-biomat/5f05c98a-143d-4770-8557-8ea1795c2e89)
- [FDA Inspection 930547 - 2015-06-11](https://www.keypedia.com/records/fda_inspections/grifols-biomat/1a9cb7c2-3294-45b7-a2cd-1fc1d8d8d986)
- [FDA Inspection 835676 - 2013-06-05](https://www.keypedia.com/records/fda_inspections/grifols-biomat/5b1de375-a411-4bbe-9b1a-e19eac435c00)
- [FDA Inspection 739338 - 2011-08-12](https://www.keypedia.com/records/fda_inspections/grifols-biomat/31383898-20e8-4355-8dfb-72013e0295d8)
- [FDA Inspection 604691 - 2009-08-13](https://www.keypedia.com/records/fda_inspections/grifols-biomat/4f7bfa8c-ff76-4a62-b278-8c8be4336f49)

Company: https://www.keypedia.com/companies/grifols-biomat/e0e507fd-a0ad-4454-be5f-e3d35a9e42f3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d